Business Context and Reporting Period
This Form 8-K filing by IRIDEX Corporation (Delaware) covers events occurring on December 23, 2014, with the report dated December 31, 2014. The filing addresses changes to the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes.
Material Changes
- Resignation: James B. Hawkins resigned from the Board of Directors, the Audit Committee, and the Nominating and Governance Committee, effective December 31, 2014.
- Appointment: Dr. George Marcellino was appointed to the Board of Directors and the Audit Committee, effective December 31, 2014.
Guidance, Outlook, and Compensation
Dr. Marcellino will receive standard compensation and option grants available to non-employee board members. This includes an initial option to purchase 15,000 shares of common stock, vesting ratably over 36 months. He is expected to execute the company's standard indemnification agreement. No financial guidance, outlook, or risk factors were disclosed in this specific filing.
Investor Verification Checklist
- Confirm the effective date of Dr. Marcellino's appointment and committee assignments.
- Verify the vesting schedule and terms of the 15,000-share option grant.
- Review the attached press release (Exhibit 99.1) for additional context on the board transition.
- Check subsequent filings for any financial impact related to the new director's compensation.